D. Sato

D. Sato, F. Barbisan, T. V. Palma, 2021, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

MOG-antibody-associated disease is different from MS and NMOSD and should be considered as a distinct disease entity – Yes

D. Sato, M. Leite, 2019, Multiple sclerosis.

Update on biomarkers in neuromyelitis optica

J. P. Garrahan, Terry J. Smith, Jacqueline Palace, 2015, Neurology: Neuroimmunology & Neuroinflammation.

Cerebrospinal Fluid Aquaporin-4 Antibody Levels in Neuromyelitis Optica Attacks

K. Fujihara, L. Steinman, T. Misu, 2014, Annals of neurology.

Aquaporin-4 antibody-positive myelitis initially biopsied for suspected spinal cord tumors: Diagnostic considerations

K. Fujihara, T. Misu, M. Aoki, 2013, Multiple sclerosis.

Clinical Spectrum and Treatment of Neuromyelitis Optica Spectrum Disorders: Evolution and Current Status

K. Fujihara, D. Sato, J. Seze, 2013, Brain pathology.

Current concept of neuromyelitis optica (NMO) and NMO spectrum disorders

K. Fujihara, D. Sato, J. de Seze, 2012, Journal of Neurology, Neurosurgery & Psychiatry.

The clinical spectrum associated with myelin oligodendrocyte glycoprotein antibodies (anti-MOG-Ab) in Thai patients

K. Fujihara, D. Sato, K. Kaneko, 2016, Multiple Sclerosis.

MRI and retinal abnormalities in isolated optic neuritis with myelin oligodendrocyte glycoprotein and aquaporin-4 antibodies: a comparative study

T. Nakazawa, K. Fujihara, T. Misu, 2015, Journal of Neurology, Neurosurgery & Psychiatry.

Treatment of MOG antibody associated disorders: results of an international survey

O. Ciccarelli, S. Broadley, A. Traboulsee, 2020, Journal of Neurology.

Treatment of MOG-IgG-associated disorder with rituximab: An international study of 121 patients.

Jacqueline Palace, F. Paul, K. Fujihara, 2020, Multiple sclerosis and related disorders.

Neuromyelitis Optica Spectrum Disorders.

K. Fujihara, D. Sato, T. Akaishi, 2017, Neuroimaging clinics of North America.

Detection of autoantibodies in central nervous system inflammatory disorders: Clinical application of cell-based assays.

Ana Paula Bornes da Silva, D. Machado, D. Sato, 2019, Multiple sclerosis and related disorders.

Immunobiology of neuromyelitis optica spectrum disorders

D. Sato, G. Hansel, Daissy Liliana Mora Cuervo, 2022, Current Opinion in Neurobiology.

Atypical presentations of neuromyelitis optica.

K. Fujihara, D. Sato, 2011, Arquivos de neuro-psiquiatria.

Detection of MOG-IgG by cell-based assay: moving from discovery to clinical practice

D. Sato, P. Waters, M. Woodhall, 2020, Neurological Sciences.

Detection of MOG-IgG in Clinical Samples by Live Cell-Based Assays: Performance of Immunofluorescence Microscopy and Flow Cytometry

D. Sato, G. Hansel, G. Ávila, 2021, Frontiers in Immunology.

Bilateral frontal cortex encephalitis and paraparesis in a patient with anti-MOG antibodies

K. Fujihara, T. Misu, Mika Watanabe, 2017, Journal of Neurology, Neurosurgery, and Psychiatry.

Different etiologies and prognoses of optic neuritis in demyelinating diseases

T. Nakazawa, K. Fujihara, S. Mugikura, 2016, Journal of Neuroimmunology.

Relapsing optic neuritis and isolated transverse myelitis are the predominant clinical phenotypes for patients with antibodies to myelin oligodendrocyte glycoprotein in India

K. Fujihara, D. Sato, Toshiyuki Takahashi, 2016, Multiple sclerosis journal - experimental, translational and clinical.

Viral encephalitis: a practical review on diagnostic approach and treatment

D. Sato, Bruna Klein da Costa, 2019, Jornal de pediatria.

Influenza-associated MOG antibody-positive longitudinally extensive transverse myelitis: a case report

K. Fujihara, N. Hattori, D. Sato, 2014, BMC Neurology.

Sometimes less is more in multiple sclerosis drug switching.

D. Sato, Bruna Klein da Costa, 2016, Arquivos de neuro-psiquiatria.

MOG-IgG serological status matters in paediatric ADEM

K. Fujihara, T. Misu, D. Sato, 2014, Journal of Neurology, Neurosurgery & Psychiatry.

Post-vaccination MDEM associated with MOG antibody in a subclinical Chlamydia infected boy

H. Nakajima, Y. Shigeri, D. Sato, 2016, Brain and Development.

Clinical features and long-term outcome of a group of Japanese children with inflammatory central nervous system disorders and seropositivity to myelin-oligodendrocyte glycoprotein antibodies

K. Fujihara, T. Misu, K. Haginoya, 2015, Brain and Development.

Anti–N‐methyl‐D‐aspartate receptor encephalitis with multiphasic demyelination

K. Fujihara, T. Misu, M. Aoki, 2014, Annals of neurology.

Serological markers associated with neuromyelitis optica spectrum disorders in South India

K. Fujihara, D. Sato, Toshiyuki Takahashi, 2016, Annals of Indian Academy of Neurology.

Idiopathic aquaporin-4 antibody negative longitudinally extensive transverse myelitis

K. Fujihara, Jae-Won Hyun, Su-Hyun Kim, 2015, Multiple sclerosis.

Severe demyelination but no astrocytopathy in clinically definite neuromyelitis optica with anti-myelin-oligodendrocyte glycoprotein antibody

K. Fujihara, T. Misu, M. Aoki, 2015, Multiple sclerosis.

Diagnosis of myelin oligodendrocyte glycoprotein antibody-associated disease: International MOGAD Panel proposed criteria

Jacqueline Palace, B. Banwell, K. Fujihara, 2023, The Lancet Neurology.

MOG cell-based assay detects non-MS patients with inflammatory neurologic disease

K. Fujihara, Jacqueline A Palace, T. Misu, 2015, Neurology: Neuroimmunology & Neuroinflammation.

Neurological sequelae after encephalitis associated with herpes simplex virus in children: systematic review and meta-analysis

R. Mattiello, D. Sato, Sara Kvitko de Moura, 2023, BMC Infectious Diseases.

A coffee enriched with guarana, selenium, and l-carnitine (GSC) has nutrigenomic effects on oxi-inflammatory markers of relapsing-remitting multiple sclerosis patients: A pilot study.

D. Sato, F. Barbisan, I. D. da Cruz, 2023, Multiple sclerosis and related disorders.

Experimental Models of Neuroimmunological Disorders: A Review

Ana Paula Bornes da Silva, D. Machado, D. Sato, 2020, Frontiers in Neurology.

Consensus recommendations for the diagnosis and treatment of primary progressive multiple sclerosis in Latin America

J. Correale, A. Carrá, E. Cristiano, 2018, Journal of Neurological Sciences.

Myelin oligodendrocyte glycoprotein immunoglobulin G‐associated disease: An overview

K. Fujihara, T. Misu, S. Nishiyama, 2018 .

Th17 Cells Pathways in Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorders: Pathophysiological and Therapeutic Implications

Jefferson Becker, K. Fujihara, D. Sato, 2016, Mediators of inflammation.

Highly encephalitogenic aquaporin 4-specific T cells and NMO-IgG jointly orchestrate lesion location and tissue damage in the CNS

K. Fujihara, H. Lassmann, T. Misu, 2015, Acta Neuropathologica.

Neutralizing antibodies are associated with a reduction of interferon-β efficacy during the treatment of Japanese multiple sclerosis patients.

Y. Itoyama, K. Fujihara, G. Giovannoni, 2012, The Tohoku journal of experimental medicine.

Treatment of neuromyelitis optica: an evidence based review.

K. Fujihara, D. Sato, D. Callegaro, 2012, Arquivos de neuro-psiquiatria.

Persistent MOG-IgG positivity is a predictor of recurrence in MOG-IgG-associated optic neuritis, encephalitis and myelitis

D. Sato, D. Callegaro, M. Pitombeira, 2018, Multiple sclerosis.

Myelin-oligodendrocyte glycoprotein antibody-associated disease

O. Ciccarelli, Jacqueline Palace, A. Traboulsee, 2021, The Lancet Neurology.

Leukoencephalopathy resolution after atypical mycobacterial treatment: a case report

K. Fujihara, T. Misu, R. Nitrini, 2015, BMC Neurology.

Brazilian Consensus for the Treatment of Multiple Sclerosis: Brazilian Academy of Neurology and Brazilian Committee on Treatment and Research in Multiple Sclerosis

A. Damasceno, R. Domingues, D. Sato, 2018, Arquivos de Neuro-Psiquiatria.

MRI characteristics of neuromyelitis optica spectrum disorder

F. Paul, B. Banwell, K. Fujihara, 2015, Neurology.

Long-term safety of azathioprine for treatment of neuromyelitis optica spectrum disorders

D. Sato, D. Callegaro, M. Pitombeira, 2020, Arquivos de Neuro-Psiquiatria.

MOG antibody–positive, benign, unilateral, cerebral cortical encephalitis with epilepsy

K. Fujihara, T. Misu, S. Nishiyama, 2017, Neurology: Neuroimmunology & Neuroinflammation.

Latin American consensus recommendations for management and treatment of neuromyelitis optica spectrum disorders in clinical practice.

J. Correale, E. Cristiano, D. Sato, 2020, Multiple sclerosis and related disorders.

Neuromyelitis optica spectrum disorders: a review with a focus on children and adolescents

D. Sato, C. Rimkus, D. Callegaro, 2021, Arquivos de Neuro-Psiquiatria.

Mechanisms of myelin repair, MRI techniques and therapeutic opportunities in multiple sclerosis.

J. Hata, J. Nakahara, D. Sato, 2021, Multiple sclerosis and related disorders.

Neuromyelitis optica should be classified as an astrocytopathic disease rather than a demyelinating disease

Y. Itoyama, K. Fujihara, H. Lassmann, 2012 .

MOG-IgG-Associated Optic Neuritis, Encephalitis, and Myelitis: Lessons Learned From Neuromyelitis Optica Spectrum Disorder

K. Fujihara, D. Sato, D. Callegaro, 2018, Front. Neurol..

Characterization of pain syndromes in patients with neuromyelitis optica.

D. Ciampi de Andrade, V. Silva, R. Galhardoni, 2020, European journal of pain.

Myelin injury without astrocytopathy in neuroinflammatory disorders with MOG antibodies

K. Fujihara, T. Misu, M. Sepúlveda, 2016, Journal of Neurology, Neurosurgery & Psychiatry.

International Delphi Consensus on the Management of AQP4-IgG+ NMOSD

Jacqueline Palace, K. Fujihara, D. Rotstein, 2023, Neurology: Neuroimmunology & Neuroinflammation.

Status of the neuromyelitis optica spectrum disorder in Latin America.

J. Correale, V. Rivera, A. Carrá, 2021, Multiple sclerosis and related disorders.

Clinical spectrum of inflammatory central nervous system demyelinating disorders associated with antibodies against myelin oligodendrocyte glycoprotein

D. Sato, T. Akaishi, I. Nakashima, 2019, Neurochemistry International.

Latin American consensus recommendations for management and treatment of neuromyelitis optica spectrum disorders in clinical practice[Mult Scler Relat Disord. 2020 Oct;45:102428].

J. Correale, E. Cristiano, D. Sato, 2021, Multiple sclerosis and related disorders.

AQP4 antibody serostatus

K. Fujihara, D. Sato, 2013, Neurology.

Quality of life goes beyond the medical priorities in multiple sclerosis: assessing the impact of social support network.

D. Sato, Renata Brant de Souza, 2017, Arquivos de neuro-psiquiatria.

Severely exacerbated neuromyelitis optica rat model with extensive astrocytopathy by high affinity anti-aquaporin-4 monoclonal antibody

K. Fujihara, M. Yasui, T. Misu, 2015, Acta Neuropathologica Communications.

Treatment of MOG-IgG associated disease in paediatric patients: A systematic review.

B. Banwell, D. Sato, Bruna Klein da Costa, 2021, Multiple Sclerosis and Related Disorders.

Anti-MOG (Myelin Oligodendrocyte Glycoprotein)–Positive Severe Optic Neuritis with Optic Disc Ischaemia and Macular Star

K. Fujihara, M. Monteiro, D. Sato, 2015, Neuro-ophthalmology.

Decreased convulsive threshold and memory loss after anti-NMDAR positive CSF injection in zebrafish

D. Sato, C. Bonan, S. Altenhofen, 2021, Journal of Neuroimmunology.

Fulminant demyelinating encephalomyelitis

K. Fujihara, H. Lassmann, P. Rhomberg, 2015, Neurology: Neuroimmunology & Neuroinflammation.

2014 Joint Americas Committee for Treatment and Research in Multiple Sclerosis–European Committee for Treatment and Research in Multiple Sclerosis Meeting

D. Sato, 2015 .

AQP4-IgG NMOSD, MOGAD, and double-seronegative NMOSD: is it possible to depict the antibody subtype using magnetic resonance imaging?

D. Sato, D. C. Fragoso, C. Rimkus, 2022, Arquivos de Neuro-Psiquiatria.

Asymptomatic MRI lesions in pediatric-onset AQP4-IgG positive NMOSD.

J. A. da Paz, D. Sato, C. Rimkus, 2022, Multiple sclerosis and related disorders.

Reduced quality of life in a pediatric-onset Neuromyelitis optica spectrum disorders cohort.

J. A. da Paz, D. Sato, C. Rimkus, 2021, Multiple sclerosis and related disorders.

Differential diagnosis of longitudinally extensive transverse myelitis

D. Sato, R. Simm, P. Marchiori, 2013 .

Correlation between the corpus callosum index and brain atrophy, lesion load, and cognitive dysfunction in multiple sclerosis.

A. Franco, D. Sato, I. Gomes, 2018, Multiple sclerosis and related disorders.

Treatment of MOG-IgG-associated demyelination with Rituximab: a multinational study of 98 patients

F. Paul, K. Fujihara, B. Weinshenker, 2018 .

MOG-IgG associated optic neuritis is not multiple sclerosis

D. Sato, J. Becker, G. Passos, 2017, Arquivos de Neuro-Psiquiatria.

Time to target brain atrophy and neurodegeneration in multiple sclerosis.

D. Sato, Bruna Klein da Costa, 2016, Arquivos de neuro-psiquiatria.

Fulminant demyelinating encephalomyelitis Insights from antibody studies and neuropathology

K. Fujihara, H. Lassmann, M. Reindl, 2022 .

Simultaneous bilateral optic neuritis and longitudinally extensive transverse myelitis following vaccination against COVID-19: A case report

W. Borelli, D. Sato, G. Hansel, 2021, Neuroimmunology Reports.

Case of autoantibodies against N‐methyl‐D‐aspartate receptor+/antibodies against myelin‐oligodendrocyte glycoprotein+ multiphasic acute disseminated encephalomyelitis (ADEM)

K. Fujihara, T. Misu, D. Sato, 2014 .

Healthy aging during the COVID-19 pandemic

D. Sato, G. Hansel, 2021 .

Treatment of MOG antibody associated disorders: results of an international survey

O. Ciccarelli, A. Traboulsee, P. Huppke, 2020, Journal of Neurology.